Cellular Senescence Agent
The Cellular Senescence Agent provides comprehensive AI-driven analysis of cellular senescence signatures for aging research, cancer biology, and senolytic therapeutic development.
When to Use This Skill
- When identifying senescent cells in tissue or single-cell data.
- To analyze senescence-associated secretory phenotype (SASP).
- For predicting senolytic drug sensitivity.
- When studying therapy-induced senescence in cancer.
- To assess senescence burden in aging and disease.
Core Capabilities
Senescence Scoring: Calculate senescence signatures from transcriptomic data.
SASP Profiling: Characterize senescence-associated secretory phenotype composition.
Single-Cell Detection: Identify senescent cells in scRNA-seq data.
Senolytic Prediction: Predict sensitivity to senolytic drugs.
Tissue Aging: Assess senescence burden across tissues.
Cancer Senescence: Analyze therapy-induced senescence.
Senescence Markers
| Category |
Markers |
Detection |
| Cell cycle |
p16INK4a, p21CIP1, p53 |
Expression, IHC |
| SA-β-gal |
GLB1 (lysosomal) |
Activity assay |
| SASP |
IL-6, IL-8, MMP3, PAI-1 |
Expression, secretion |
| DNA damage |
γH2AX, 53BP1 foci |
Immunofluorescence |
| Morphology |
Enlarged, flattened |
Imaging |
| Epigenetic |
SAHF, SAHMs |
Chromatin marks |
Workflow
Input: Bulk or single-cell RNA-seq, proteomics, imaging data.
Signature Scoring: Apply senescence gene signatures.
SASP Analysis: Profile secretory phenotype.
Cell Identification: Flag senescent cells (single-cell).
Senolytic Prediction: Match to drug sensitivity profiles.
Burden Estimation: Quantify senescence load.
Output: Senescence scores, SASP profile, drug recommendations.
Example Usage
User: "Analyze senescence signatures in this aging tissue dataset and identify senolytic candidates."
Agent Action:
python3 Skills/Longevity_Aging/Cellular_Senescence_Agent/senescence_analyzer.py \
--rnaseq tissue_expression.tsv \
--singlecell tissue_scrnaseq.h5ad \
--signatures fridman_sasp,reactome_senescence \
--senolytic_prediction true \
--tissue liver \
--output senescence_report/
Senescence Gene Signatures
| Signature |
Genes |
Application |
| Fridman (2017) |
CDKN1A, CDKN2A, SERPINE1... |
Pan-senescence |
| SenMayo |
125 genes |
Tissue senescence |
| SASP Core |
IL6, IL8, CXCL1, MMP1... |
Secretory phenotype |
| p16/p21 pathway |
CDKN2A, CDKN1A, MDM2... |
Cell cycle arrest |
SASP Components
Pro-inflammatory:
- Interleukins: IL-1α/β, IL-6, IL-8
- Chemokines: CXCL1, CXCL2, CCL2
- Growth factors: TGF-β, VEGF
Matrix Remodeling:
- MMPs: MMP1, MMP3, MMP10
- Serpins: PAI-1 (SERPINE1)
Effects on Microenvironment:
- Paracrine senescence spread
- Immune cell recruitment
- ECM remodeling
- Tumor promotion (chronic) vs suppression (acute)
Senolytic Drugs
| Drug |
Target |
Clinical Status |
| Dasatinib |
Src/tyrosine kinases |
Trials (with Q) |
| Quercetin |
PI3K, serpins |
Trials (with D) |
| Navitoclax |
BCL-2/BCL-xL |
Trials |
| Fisetin |
Multiple |
Early trials |
| UBX1325 |
BCL-xL |
Phase 2 (macular) |
AI/ML Components
Senescence Classifier:
- Multi-gene signature scoring
- ML classifiers on expression
- Single-cell senescence probability
Drug Response:
- GDSC/CCLE senescence sensitivity
- SASP-drug correlations
- Synergy predictions
Aging Clock Integration:
- Epigenetic age correlation
- Transcriptomic age
- Senescence-aging relationships
Cancer Applications
Therapy-Induced Senescence (TIS):
- Chemotherapy, radiation
- CDK4/6 inhibitors (palbociclib)
- Dual outcomes: tumor suppression vs SASP-driven recurrence
Senescence + Senolytics:
- Induce senescence → clear with senolytics
- "One-two punch" approach
- Clinical trials ongoing
Prerequisites
- Python 3.10+
- Gene signature tools (GSVA, ssGSEA)
- Single-cell analysis (Scanpy)
- Drug response databases
Related Skills
- Single_Cell - For scRNA-seq analysis
- Cancer_Metabolism_Agent - For metabolic senescence
- Tumor_Microenvironment - For SASP effects
Research Applications
- Aging Research: Quantify senescence burden
- Cancer Therapy: Monitor TIS response
- Drug Development: Senolytic efficacy
- Fibrosis: Senescence in fibrotic disease
- Regeneration: Senescence in tissue repair
Author
AI Group - Biomedical AI Platform
1---2name: cellular-senescence-agent-23description: AI-powered analysis of cellular senescence for aging research, cancer therapy response, and senolytic drug development.4license: MIT5---67# Cellular Senescence Agent89The **Cellular Senescence Agent** provides comprehensive AI-driven analysis of cellular senescence signatures for aging research, cancer biology, and senolytic therapeutic development.1011## When to Use This Skill1213* When identifying senescent cells in tissue or single-cell data.14* To analyze senescence-associated secretory phenotype (SASP).15* For predicting senolytic drug sensitivity.16* When studying therapy-induced senescence in cancer.17* To assess senescence burden in aging and disease.1819## Core Capabilities20211. **Senescence Scoring**: Calculate senescence signatures from transcriptomic data.22232. **SASP Profiling**: Characterize senescence-associated secretory phenotype composition.24253. **Single-Cell Detection**: Identify senescent cells in scRNA-seq data.26274. **Senolytic Prediction**: Predict sensitivity to senolytic drugs.28295. **Tissue Aging**: Assess senescence burden across tissues.30316. **Cancer Senescence**: Analyze therapy-induced senescence.3233## Senescence Markers3435| Category | Markers | Detection |36|----------|---------|-----------|37| Cell cycle | p16INK4a, p21CIP1, p53 | Expression, IHC |38| SA-β-gal | GLB1 (lysosomal) | Activity assay |39| SASP | IL-6, IL-8, MMP3, PAI-1 | Expression, secretion |40| DNA damage | γH2AX, 53BP1 foci | Immunofluorescence |41| Morphology | Enlarged, flattened | Imaging |42| Epigenetic | SAHF, SAHMs | Chromatin marks |4344## Workflow45461. **Input**: Bulk or single-cell RNA-seq, proteomics, imaging data.47482. **Signature Scoring**: Apply senescence gene signatures.49503. **SASP Analysis**: Profile secretory phenotype.51524. **Cell Identification**: Flag senescent cells (single-cell).53545. **Senolytic Prediction**: Match to drug sensitivity profiles.55566. **Burden Estimation**: Quantify senescence load.57587. **Output**: Senescence scores, SASP profile, drug recommendations.5960## Example Usage6162**User**: "Analyze senescence signatures in this aging tissue dataset and identify senolytic candidates."6364**Agent Action**:65```bash66python3 Skills/Longevity_Aging/Cellular_Senescence_Agent/senescence_analyzer.py \67 --rnaseq tissue_expression.tsv \68 --singlecell tissue_scrnaseq.h5ad \69 --signatures fridman_sasp,reactome_senescence \70 --senolytic_prediction true \71 --tissue liver \72 --output senescence_report/73```7475## Senescence Gene Signatures7677| Signature | Genes | Application |78|-----------|-------|-------------|79| Fridman (2017) | CDKN1A, CDKN2A, SERPINE1... | Pan-senescence |80| SenMayo | 125 genes | Tissue senescence |81| SASP Core | IL6, IL8, CXCL1, MMP1... | Secretory phenotype |82| p16/p21 pathway | CDKN2A, CDKN1A, MDM2... | Cell cycle arrest |8384## SASP Components8586**Pro-inflammatory**:87- Interleukins: IL-1α/β, IL-6, IL-888- Chemokines: CXCL1, CXCL2, CCL289- Growth factors: TGF-β, VEGF9091**Matrix Remodeling**:92- MMPs: MMP1, MMP3, MMP1093- Serpins: PAI-1 (SERPINE1)9495**Effects on Microenvironment**:96- Paracrine senescence spread97- Immune cell recruitment98- ECM remodeling99- Tumor promotion (chronic) vs suppression (acute)100101## Senolytic Drugs102103| Drug | Target | Clinical Status |104|------|--------|-----------------|105| Dasatinib | Src/tyrosine kinases | Trials (with Q) |106| Quercetin | PI3K, serpins | Trials (with D) |107| Navitoclax | BCL-2/BCL-xL | Trials |108| Fisetin | Multiple | Early trials |109| UBX1325 | BCL-xL | Phase 2 (macular) |110111## AI/ML Components112113**Senescence Classifier**:114- Multi-gene signature scoring115- ML classifiers on expression116- Single-cell senescence probability117118**Drug Response**:119- GDSC/CCLE senescence sensitivity120- SASP-drug correlations121- Synergy predictions122123**Aging Clock Integration**:124- Epigenetic age correlation125- Transcriptomic age126- Senescence-aging relationships127128## Cancer Applications129130**Therapy-Induced Senescence (TIS)**:131- Chemotherapy, radiation132- CDK4/6 inhibitors (palbociclib)133- Dual outcomes: tumor suppression vs SASP-driven recurrence134135**Senescence + Senolytics**:136- Induce senescence → clear with senolytics137- "One-two punch" approach138- Clinical trials ongoing139140## Prerequisites141142* Python 3.10+143* Gene signature tools (GSVA, ssGSEA)144* Single-cell analysis (Scanpy)145* Drug response databases146147## Related Skills148149* Single_Cell - For scRNA-seq analysis150* Cancer_Metabolism_Agent - For metabolic senescence151* Tumor_Microenvironment - For SASP effects152153## Research Applications1541551. **Aging Research**: Quantify senescence burden1562. **Cancer Therapy**: Monitor TIS response1573. **Drug Development**: Senolytic efficacy1584. **Fibrosis**: Senescence in fibrotic disease1595. **Regeneration**: Senescence in tissue repair160161## Author162163AI Group - Biomedical AI Platform